ArticleHealth science reports2026

Rebalancing Hemostasis: Fitusiran as a First-in-Class RNAi Therapy in Hemophilia A and B.

Raza Ur Rehman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.